Category: Esophageal cancer

Home / Established Year

Lesser-known facts about esophageal cancer

April 2023: April month is observed as esophageal cancer awareness month. Esophageal cancer is a type of cancer that affects the esophagus, the muscular tube that connects the throat to the stomach. Here are some lesser-known fac..

,

Nivolumab has been approved by the FDA for resected esophageal or gastroesophageal junction cancer

August 2021: The FDA has approved Nivolumab (Opdivo, Bristol-Myers Squibb Company) for patients with fully resected oesophagus or gastroesophageal junction (GEJ) cancer who have received neoadjuvant chemoradiotherapy and have pers..

, , , , ,

Pembrolizumab receives accelerated approval from the FDA for HER2-positive gastric cancer

August 2021: Pembrolizumab (Keytruda, Merck & Co.) in combination with trastuzumab, fluoropyrimidine-, and platinum-containing chemotherapy has been granted accelerated approval by the Food and Drug Administration for the firs..

Easily adoptable methods to improve outcomes in treatment of gastroesophageal cancers

July 9th 2021: During the European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2021, two scientists from Roswell Park Comprehensive Cancer Center were asked to share new findings on the treatment ..

Surgical treatment of gastroesophageal junction tumors

Key points for diagnosis and treatment of tumors at the junction of gastroesophagus1 Gastroesophageal junction (GEJ) adenocarcinoma occurs at the junction of the esophagus and stomach.2 Accurate preoperative staging is the key to ..

First immunotherapy approved for esophageal cancer

First immunotherapy has been approved for esophageal cancer treatment. Esophageal cancer is a common malignant tumor. The International Center for Cancer Research of the World Health Organization points out that esophageal cancer..

No signs of tumor after proton therapy in an esophageal cancer patient

  89 year old patient who suffers from esophageal cancer and who can't be operated or given chemotherapy fully recovered after proton therapy. Read the full case study over here.   Esophageal cancer Esophageal cancer i..

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy